• Gemini Bio Launches Moxi V contractpharma
    July 22, 2020
    ​Gemini Bioproducts LLC, a supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, has launched the Moxi V for precision cell analysis.
  • Gemini Bio Opens New cGMP Facility contractpharma
    June 24, 2020
    Gemini Bioproducts LLC, a supplier of cell culture reagents and a portfolio company of BelHealth Investment Partners LLC, a New York-based healthcare private equity firm, has announced the opening of a new manufacturing facility in ...
  • Gemini Bio Wins Federal Contract to Support COVID-19 Testing contractpharma
    June 15, 2020
    Will be increasing domestic production of reagents from its California facility, as well as its manufacturing footprint.
PharmaSources Customer Service